FY22. DRUG PRODUCT STABILITY STUDIES. POP 9/23/22 - 9/22/23.
$88,415N01FY2022DANIH
Murty Pharmaceuticals, Inc., Lexington KY
Investigators
Abstract
Substance Misuse
View original record on NIH RePORTER →Murty Pharmaceuticals, Inc., Lexington KY
Substance Misuse
View original record on NIH RePORTER →